Case Report: Non-Surgical Treatment of Medial Canthus Basal Cell Carcinoma Using Dual-Wavelength Fractional Laser Therapy

Authors

  • Paulina Decker, B.S. Miami Dermatology and Mohs Surgery Author
  • Miesha Merati, DO, FAAD Miami Dermatology and Mohs Surgery Author
  • Uzma Farooq, MD Skin Pathology Center Author
  • Harib Ezaldein, MD, FAAD, FACMS Miami Dermatology and Mohs Surgery Author

Keywords:

basal cell carcinoma, fractional laser, erbium glass laser, thulium laser, periocular tumors, laser dermatologic surgery, non melanoma skin cancer, medial canthus

Abstract

Basal cell carcinoma (BCC) is the most common cutaneous malignancy and is typically managed with surgical excision or Mohs micrographic surgery. However, treatment in anatomically sensitive areas such as the medial canthus may present reconstructive challenges, and alternative approaches may be considered in select patients. We report the case of a 97 year old female with a biopsy confirmed BCC of the left medial canthus treated with combined fractional 1550 nm erbium glass and 1927 nm thulium laser following tumor debulking. The procedure was utilized as a drug delivery enhancing modality with adjunctive topical 5% fluorouracil applied twice daily for 2 weeks. A follow up shave biopsy performed one month after treatment demonstrated complete histologic clearance with no residual tumor. This case highlights the potential role of dual wavelength fractional laser therapy as a non surgical treatment option for BCC in anatomically sensitive regions.

Pathology image

Downloads

Published

05/08/2026